Literature DB >> 27520906

Cabergoline can induce mania with psychotic features in bipolar I disorder: a case report.

Chiara Rovera1, Laura Cremaschi2, Amod Thanju3, Alessio Fiorentini2, Massimo Carlo Mauri2, Marta Serati2, Jean Pierre Lindenmayer4, A Carlo Altamura2.   

Abstract

Up to date, only a small evidence of psychosis induced by cabergoline is available in literature. Herein, the case of a 34-year-old bipolar patient treated with cabergoline has been described. Cabergoline is generally a safe and effective method of reducing prolactin levels and it may be associated with psychiatric side effects, including psychotic features.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar Disorder; Cabergoline; Mood Disorders; Prolactinoma; Psychosis

Mesh:

Substances:

Year:  2016        PMID: 27520906     DOI: 10.1016/j.ajp.2016.05.010

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  1 in total

Review 1.  Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist.

Authors:  Anastasia P Athanasoulia-Kaspar; Kathrin H Popp; Gunter Karl Stalla
Journal:  Endocr Connect       Date:  2018-01-29       Impact factor: 3.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.